Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 1
1961 2
1964 3
1965 3
1966 10
1967 1
1968 12
1969 3
1970 4
1971 4
1972 6
1973 3
1974 7
1975 6
1976 10
1977 13
1978 15
1979 10
1980 16
1981 20
1982 19
1983 17
1984 8
1985 19
1986 7
1987 10
1988 9
1989 14
1990 12
1991 9
1992 8
1993 8
1994 7
1995 6
1996 10
1997 9
1998 3
1999 5
2000 10
2001 6
2002 7
2003 6
2004 8
2005 12
2006 13
2007 15
2008 10
2009 11
2010 16
2011 19
2012 13
2013 18
2014 23
2015 22
2016 9
2017 12
2018 10
2019 20
2020 14
2021 13
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

594 results
Results by year
Filters applied: . Clear all
Page 1
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.
Adams D, Gonzalez-Duarte A, O'Riordan WD, Yang CC, Ueda M, Kristen AV, Tournev I, Schmidt HH, Coelho T, Berk JL, Lin KP, Vita G, Attarian S, Planté-Bordeneuve V, Mezei MM, Campistol JM, Buades J, Brannagan TH 3rd, Kim BJ, Oh J, Parman Y, Sekijima Y, Hawkins PN, Solomon SD, Polydefkis M, Dyck PJ, Gandhi PJ, Goyal S, Chen J, Strahs AL, Nochur SV, Sweetser MT, Garg PP, Vaishnaw AK, Gollob JA, Suhr OB. Adams D, et al. Among authors: dyck pj. N Engl J Med. 2018 Jul 5;379(1):11-21. doi: 10.1056/NEJMoa1716153. N Engl J Med. 2018. PMID: 29972753 Free article. Clinical Trial.
Multifocal motor neuropathy: controversies and priorities.
Yeh WZ, Dyck PJ, van den Berg LH, Kiernan MC, Taylor BV. Yeh WZ, et al. Among authors: dyck pj. J Neurol Neurosurg Psychiatry. 2020 Feb;91(2):140-148. doi: 10.1136/jnnp-2019-321532. Epub 2019 Sep 11. J Neurol Neurosurg Psychiatry. 2020. PMID: 31511307 Review.
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.
Benson MD, Waddington-Cruz M, Berk JL, Polydefkis M, Dyck PJ, Wang AK, Planté-Bordeneuve V, Barroso FA, Merlini G, Obici L, Scheinberg M, Brannagan TH 3rd, Litchy WJ, Whelan C, Drachman BM, Adams D, Heitner SB, Conceição I, Schmidt HH, Vita G, Campistol JM, Gamez J, Gorevic PD, Gane E, Shah AM, Solomon SD, Monia BP, Hughes SG, Kwoh TJ, McEvoy BW, Jung SW, Baker BF, Ackermann EJ, Gertz MA, Coelho T. Benson MD, et al. Among authors: dyck pj. N Engl J Med. 2018 Jul 5;379(1):22-31. doi: 10.1056/NEJMoa1716793. N Engl J Med. 2018. PMID: 29972757 Free article. Clinical Trial.
Toxic Neuropathies.
Karam C, Dyck PJ. Karam C, et al. Among authors: dyck pj. Semin Neurol. 2015 Aug;35(4):448-57. doi: 10.1055/s-0035-1558977. Epub 2015 Oct 6. Semin Neurol. 2015. PMID: 26502767 Review.
Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial.
Brannagan TH, Wang AK, Coelho T, Waddington Cruz M, Polydefkis MJ, Dyck PJ, Plante-Bordeneuve V, Berk JL, Barroso F, Merlini G, Conceição I, Hughes SG, Kwoh J, Jung SW, Guthrie S, Pollock M, Benson MD, Gertz M; NEURO-TTR open-label extension investigators. Brannagan TH, et al. Among authors: dyck pj. Eur J Neurol. 2020 Aug;27(8):1374-1381. doi: 10.1111/ene.14285. Epub 2020 May 29. Eur J Neurol. 2020. PMID: 32343462 Free PMC article. Clinical Trial.
Vasculitic neuropathies.
Gwathmey KG, Burns TM, Collins MP, Dyck PJ. Gwathmey KG, et al. Among authors: dyck pj. Lancet Neurol. 2014 Jan;13(1):67-82. doi: 10.1016/S1474-4422(13)70236-9. Lancet Neurol. 2014. PMID: 24331794 Review.
Lumbosacral plexopathy.
Dyck PJ, Thaisetthawatkul P. Dyck PJ, et al. Continuum (Minneap Minn). 2014 Oct;20(5 Peripheral Nervous System Disorders):1343-58. doi: 10.1212/01.CON.0000455877.60932.d3. Continuum (Minneap Minn). 2014. PMID: 25299286 Review.
594 results